Aurora Cannabis vs. Aphria Inc: Will Data Science Deliver Returns for Stock Investors?

Will data analytics help Aurora Cannabis recover lost market share to deliver good returns for patient stock investors?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Management at Aphria Inc (TSX:APHA)(NASDAQ:APHA) made quite an unbelievable and yet intriguing claim in its fiscal fourth-quarter 2020 results published in July. It refuted a general market sentiment that plunged marijuana stocks over the past several months. Interestingly, Aurora Cannabis‘ (TSX:ACB)(NYSE:ACB) new CEO Miguel Martin is of a similar mind. He will use Aphria’s proven strategy to revive ACB’s ailing fortunes.

Could a data-driven strategy deliver the revenue growth that Aurora Cannabis’s stock’s investors have been patiently waiting for?

Aphria’s bold data analytics claims

Marijuana industry analysts believe that the Canadian pot market is saturated and oversupplied right now. A surge in inventory across the industry value chain supports that claim.

Most noteworthy, HEXO, Canopy Growth Corp, and Aurora’s strategic asset disposals, layoffs, and shutdowns of production plants are evidence to this conclusion. New retail stores across the provinces, and perhaps lower pot prices to match underground market prices could help grow the market and reduce channel inventory levels…so everyone seems to believe.

Alas, Aphria is of a different opinion.

In a section headlined An Inconvenient Truth – Over or Undersupply in the Cannabis Market in the July 28 published management discussion and analysis (MD&A), the marijuana producer strongly disputes analyst opinions.

“Aphria believes that it is too simplistic to conclude that the Canadian cannabis market, as a whole, is in fact over-supplied.The company said and went on to claim that:

“Opportunities exist where cannabis is being undersupplied in certain channels and consumer needs are not yet met… using data analytics and understanding consumer preferences, the company can continue to strategically gain more market share in these categories.”

That was a bold claim. Actually, it’s hard to dismiss APHA’s claim. The results were there to prove it.

Data analytics gave APHA a competitive edge

Aphria has used data science to find and identify undersupplied niches in the marijuana market.

It discovered that the vapes category has a high trial rate for cannabis consumers but there was not enough product differentiation. The company developed specially terpene blends and cannabinoid ratios targeted at satisfying under-served niches and the strategy saw positive consumer feedback and repeat purchases. 

 Further, the same approach was used in dry flower products. Results were an increase in market share with minimal and reasonable price reductions. Winning market share in higher-margin products is the kind of progress any business would want to report.

Unfortunately, Aurora took a different path over the past few quarters. The company concentrated on pushing its value brand. Competitors followed suit, and the result was high sales volumes yet with declining total revenue.

Will data science win the game for Aurora Cannabis stock investors?

Aurora Cannabis has been losing ground in the high-margin consumer cannabis segment for several quarters now. The newly installed CEO Miguel Martin has a tough task to turn the ship around during a perfect storm. The man believes that data analytics results from the United States pot markets can help identify good opportunities in the Canadian recreational market.

Aurora is taking the game to competitors in a bid to recover lost ground in the high margin pot categories. Using data analytics, Miguel will work on reviving premium product lines. He believes provincial wholesalers and retailers in Canada are very much interested and willing to move such product categories. This is the company’s identified strategy to improve gross profits and reach its positive adjusted EBITDA and cash flow targets in 2021.

Foolish bottom line

Competition is tough in the adult-use marijuana market, and it’s getting bloody. Following Aphria’s success, ACB is turning to data science to outwit the competition. Notably, if the strategy works, then Aurora Cannabis’s stock price could violently recover from current all-time lows.

That said, competitors will use the same tools to defend market share. Retailers Namaste Technologies and Fire & Flower are licensing their AI-powered data analytics software to third parties. HEXO and Canopy Growth once advertised marketing roles that required data analytics experience.

The competition game has gotten to a new level in the Canadian recreational market. Let’s see who wins the game for marijuana stock investors.

Should you invest $1,000 in Aurora Cannabis right now?

Before you buy stock in Aurora Cannabis, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurora Cannabis wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and Namaste Technologies.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »